(Q36728319)

15 August 2017

1 reference

title

Localised carcinoma of the prostate: a paradigm of uncertainty (English)

1 reference

15 August 2017

Sandhu SS

1

1 reference

15 August 2017

Kaisary AV

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Postgraduate Medical Journal

15 August 2017

1 reference

15 August 2017

73

1 reference

15 August 2017

865

1 reference

15 August 2017

691-696

1 reference

Prostate cancer. Radiation therapy for localized disease

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Localized prostate carcinoma. Surgical management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Transrectal US of the prostate: is the technology leading the science?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Natural history of localised prostatic cancer managed by conservative therapy alone

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Staging of prostate cancer. Value of ultrasonography.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Ultrasound guided transrectal core biopsies of the palpably abnormal prostate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

State of the art: endorectal sonography of the prostate gland

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Early detection of prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

An evaluation of the needle biopsy in the diagnosis of prostatic carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Technetium-99M polyphosphate bone scanning in carcinoma of the prostate.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Total prostatectomy for clinically localized prostatic cancer: long-term results

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Natural history of localised prostatic cancer. A population-based study in 223 untreated patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Imaging of patients with stage D prostatic carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Expectant management of localized prostatic cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Deferred treatment in clinically localised prostatic carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Serum prostate-specific antigen and the biologic progression of prostate cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Utility of preoperative serumprostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2431575

Is prostate cancer worth diagnosing?

5 September 2018

1 reference

12 December 2020

The echogenic focus in prostatic sonograms, with xeroradiographic and histopathologic correlation

1 reference

12 December 2020

Prostatic disorders: MR imaging at 1.5 T

1 reference

12 December 2020

The accuracy of CT in the staging of carcinoma of the prostate

1 reference

12 December 2020

Prostatic carcinoma: staging with MR imaging at 1.5 T

1 reference

12 December 2020

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

12 December 2020

Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results

1 reference

12 December 2020

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

12 December 2020

Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup

1 reference

12 December 2020

Using PSA to screen for prostate cancer. The Washington University experience

1 reference

12 December 2020

Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate

1 reference

12 December 2020

Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density

1 reference

12 December 2020

The Impact of Current Staging Procedures in Assessing Disease Extent of Prostatic Adenocarcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.73.865.691

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

9519179

1 reference